Clinical trial
Phase I Clinical Trials of Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer
NCT04464213 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Clinical Trials of Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer
- Lead sponsor
- Beijing Tongren Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- November 1, 2020
- Completion date
- December 31, 2023
- Enrollment
- 43 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer